文章摘要
Mmengting Dong,Jiayu Sheng,Chunyang Li,Patiguli·JIAPAER,Xiaofei Li,Minjia Yuan,Xiaohong Xue,Ke Jiang. CD14 macrophage and IL-10 levels in the. Oncol Transl Med, 2022, 8: 165-172.
乳腺癌外周血CD14巨噬细胞与IL-10联合检测的诊断价值评估
CD14 macrophage and IL-10 levels in the
Received:November 27, 2021  Revised:August 09, 2022
DOI:10.1007/s10330-021-0539-9
中文关键词: 乳腺癌;巨噬细胞;IL-10;外周血;诊断价值
英文关键词: breast cancer; macrophage; IL-10; peripheral blood; diagnostic value
基金项目:Supported by grants from the National Natural Science Foundation of China (No. 82104952, No. 82004240), Special project for clinical
Author NameAffiliationE-mail
Mmengting Dong Department of Breast Diseases, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China nancyd33@163.com 
Jiayu Sheng Department of Breast Diseases, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China  
Chunyang Li Department of Breast Diseases, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China  
Patiguli·JIAPAER Department of Breast Diseases, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China  
Xiaofei Li Department of Breast Diseases, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China  
Minjia Yuan Department of Breast Diseases, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China  
Xiaohong Xue Department of Breast Diseases, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China  
Ke Jiang* Department of Breast Diseases, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China surgeonjk@163.com 
Hits: 4216
Download times: 5032
中文摘要:
  【摘要】 目的 探讨乳腺癌外周血中CD14巨噬细胞与IL-10联合检测的诊断价值。 方法 采用流式细胞术检测乳腺癌患者与健康对照组的外周血CD14巨噬细胞水平,采用酶联免疫吸附法(ELISA)检测两组外周血IL-10表达水平,完成CD14巨噬细胞各组群与IL-10的联合检测模型建立,利用受试者工作特征( receiver operating characteristic , ROC) 曲线分析检验CD14巨噬细胞各组群、IL-10以及联合检测的诊断效能,并通过卡方检验得到以上指标与临床病理特征的关系。另选取乳腺良恶性患者检测外周血,采用同样的方法检测CD14巨噬细胞与IL-10水平,进一步验证联合检测模型的诊断效能。结果 乳腺癌患者CD14+巨噬细胞群及IL-10表达水平较高,与健康人群呈明显差异(P<0.05),ROC曲线显示CD14+巨噬细胞与IL-10联合检测的曲线下面积(Area Under Curve,AUC)为0.830,敏感度为72.0%,特异度为87.5%,其诊断效能优于IL-10、CD14+、CD14-巨噬细胞的单独检测,以及IL-10与CD14-巨噬细胞及总巨噬细胞的联合检测结果。临床病理特征相关性分析显示CD14+巨噬细胞和IL-10联合检测与肿块大小、TNM分期、淋巴结情况、ER表达情况及Ki-67表达均明显相关(P<0.05)。验证性分析与试验结果基本一致。 结论 外周血巨噬细胞可成为乳腺癌的独立诊断标志物,CD14+巨噬细胞与IL-10联合检测具有提示预后不良,指导BC发展及病情监测的无限潜能,为乳腺癌相关巨噬细胞研究提供新思路。
英文摘要:
    Objective To explore the correlation between macrophages and interleukin-10 (IL-10 in the peripheral blood of breast cancer (BC) patients and the diagnostic value of joint detection. Methods BC patients (n = 50) and healthy controls (n = 40) were prospectively recruited. The percentage of circulating cluster of differentiation 14 (CD 14) macrophage cells was analyzed by flow cytometry, and an enzyme-linked immunosorbent assay (ELISA) was used to detect IL-10 expression levels. Receiver operating characteristic (ROC) curves were used to verify the diagnostic value of the models based on the expression of CD14 macrophage cell populations and IL-10. In addition, the association between model expression and clinicopathological characteristics was investigated. Another 30 patients with BC and 30 with benign breast disease were selected to validate the IL-10 and CD14 macrophage joint detection model using the same method. Results CD14 macrophage and IL-10 expression levels in BC patients were higher than those in healthy controls (P < 0.05). The ROC curve showed that the area under the curve (AUC) of CD14+ macrophages combined with IL-10 was 0.830, the sensitivity was 72.0%, and the specificity was 87.5%. Its diagnostic efficiency was better than all other single and joint detections. Correlation analysis of clinicopathological features showed that IL-10 and CD14+ macrophage joint detection was significantly correlated with tumor size, tumor-node-metastasis (TNM) stage, and lymph node, estrogen receptor (ER), and Ki-67 expression (P < 0.05). The validation analysis results were consistent with the test results. Conclusion Peripheral blood macrophages can be an independent diagnostic marker for BC. Joint detection of CD14- macrophages and IL-10 suggests poor prognosis, which has unlimited potential to guide BC development and provides a new theory for studying tumor-associated macrophages in BC.
View Full Text   Download reader  HTML全文
Close